MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue

Journal of Neurology

Volumn 247, Issue 7, 2000, Pages 506-509

  Colombo, Bruno ^a   Boneschi, Filippo Martinelli ^a   Rossi, Paolo ^a   Rovaris, Marco ^a   Maderna, Luca ^a   Filippi, Massimo ^a   Comi, Giancarlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Fatigue; Magnetic resonance imaging; Motor evoked potentials; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EVOKED MUSCLE RESPONSE; FATIGUE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0033884981     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150070148     Document Type: Article

References (26)

1. 1. Bakshi R, Miletich RS, Henschel K, Kinkel, et al (1999) Fatigue in multiple sclerosis: Cross-sectional correlation with brain MRI findings in 71 patients. Neurology 53:1151-1153
2. 2. Bergamaschi R, Romani A, CosiV, et al (1997) Clinical aspects of fatigue in multiple sclerosis. Funct Neurol 12:247-251
3. 3. Bertolene K, Coyle PK, Krupp LB, et al (1993) Cytokine correlates of fatigue in MS. Neurology 43:A356
4. 4. Brook RH, Ware JE, Davies A, et al (1979) Overview of adult health status measures fielded in the Rand's Health Insurance Study. Med Care 71 [Suppl]:1-55
5. 2+ ATPase activity in multiple sclerosis. Muscle Nerve 21:547-549
6. 6. Colombo B, Leocani L, Comi G, et al (1999) EEG pattern of cortical activation to voluntary movement in MS patients complaining of fatigue. Mult Scler 5 [Suppl 1]:S5-S15
7. 7. Freal JE, Kraft GH, Coryell JK (1984) Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 65:135-138
8. 8. IFNß Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655-661
9. 9. Iriarte J, Katsamakis G, De Castro P (1999) The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis. Mult Scler 5:10-16
10. 10. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC (1988) Fatigue in multiple sclerosis. Arch Neurol 45:435-437
11. 11. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121-1123
12. 12. Kurtzke JF (1983) Rating neurologic impairment in MS: an expanded disability status scale (EDSS). Neurology 33:1444-1452
13. 13. Liepert J, Kotterba S, Tegenthoff M, Malin JP (1996) Central fatigue assessed by transcranial magnetic stimulation. Muscle Nerve 19:1429-1434
14. 14. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis. Results of an international survey. Neurology 46:907-911
15. 15. Mainero C, Faroni J, Gasperini C, Filippi M, Pozzilli C, et al (1999) Fatigue and magnetic resonance imaging activity in multiple sclerosis. J Neurol 246:454-458
16. 16. Martinelli V, Comi G, Rovaris M, Filippi M, Canal N, et al (1995) Acute myelopathy of unknown aetiology: a clinical, neurophysiological and MRI study of short-and long-term prognostic factors. J Neurol 242:497-503
17. 17. Murray TJ (1985) Amantadine therapy for fatigue in multiple sclerosis. Can J Neurol Sci 12:251-254
18. 18. Ormerod IEC, Miller DH, McDonald WI, et al (1987) The role of MRI in the assessment of MS and isolated neurological lesions: a quantitative study. Brain 110:1579-1616
19. 19. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
20. 20. Provinciali L, Ceravolo MG, Bartolini M, et al (1999) A multidimensional assessment of multiple sclerosis: relationships between disability domains. Acta Neurol Scand 100:156-162
21. 21. Roelcke U, Kappos L, Lechner-Scott J, Steck A, Leenders KL, et al (1997) Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue. Neurology 48:1566-1571
22. 22. Rudick RA, Barna BP (1990) Serum interleukin 2 and soluble interleukin 2 receptor in patients with multiple sclerosis who are experiencing severe fatigue. Arch Neurol 47:254-255
23. 23. Sandroni P, Walker C, Starr A (1992) Fatigue in patients with multiple sclerosis. Motor pathway conduction and event-related potentials. Arch Neurol 49:517-524
24. 24. Sheean GL, Murray NMF, Rothwell JC, Miller DH, Thompson AJ (1997) An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain 120:299-315
25. 25. Stewart AL, Hays RD, Ware JE (1988) The MOS Short Form General Health Survey: reliability and validity in a patient population. Med Care 26:724-735
26. 26. Van der Werf SP, Jongen PJ, Hommes OR, Bleijenberg G, et al (1998) Fatigue in multiple sclerosis: interrelations between fatigue complaints, cerebral MRI abnormalities and neurological disability. J Neurol Sci 160:164-170